Specialized pro‐resolving lipid mediators in experimental periodontitis: A systematic review
- 19 September 2018
- journal article
- review article
- Published by Wiley in Oral Diseases
- Vol. 25 (5) , 1265-1276
Abstract
Recently, several studies demonstrated the potential of using specialized pro‐resolving lipid mediators (SPMs), as a novel approach, in treating periodontitis in pre‐clinical models. This review aimed to systematically evaluate the biological actions of SPMs on periodontal tissues in animals with experimentally induced periodontitis. This systematic review was performed by following the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) guidelines. Studies were searched in three databases. Meta‐analysis was not performed because of the data heterogeneity. Study quality was assessed using Systematic Review Centre for Laboratory Animal Experimentation (SYRCLE) Risk of Bias tool. Six studies using an experimental periodontitis model to test the efficacy of SPMs were selected. Resolvin E1 and lipoxins were topically applied to treat experimental periodontitis. Alveolar bone loss could be significantly prevented and regenerated by applying SPMs, when compared to the control group. The dosages of SPMs and the periods of disease induction varied based on the pre‐clinical model employed. Two studies further demonstrated the positive shift in microbial composition, in line with positive shift in inflammatory status, that are regulated by SPMs. Clinical studies are needed to optimize the application of SPMs in treating periodontal diseases in humans.Keywords
This publication has 33 references indexed in Scilit:
- Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediatorsBlood, 2012
- Infection regulates pro-resolving mediators that lower antibiotic requirementsNature, 2012
- Macrophage proresolving mediator maresin 1 stimulates tissue regeneration and controls painThe FASEB Journal, 2012
- Antimicrobial Aspects of Inflammatory Resolution in the Mucosa: A Role for Proresolving MediatorsThe Journal of Immunology, 2011
- Cutting Edge: Humanized Nano-Proresolving Medicines Mimic Inflammation-Resolution and Enhance Wound HealingThe Journal of Immunology, 2011
- Anti-inflammatory and pro-resolving properties of benzo-lipoxin A4 analogsProstaglandins, Leukotrienes and Essential Fatty Acids, 2009
- An endogenous regulator of inflammation, resolvin E1, modulates osteoclast differentiation and bone resorptionBritish Journal of Pharmacology, 2008
- Annexin 1 mediates the rapid anti-inflammatory effects of neutrophil-derived microparticlesBlood, 2008
- Resolution of in flammation: state of the art, definitions and termsThe FASEB Journal, 2007
- Resolution of inflammation: the beginning programs the endNature Immunology, 2005